|
|
Spotlight on HDL-raising Therapies: Insights From the Torcetrapib Trials
|
| Link ID |
5240 |
| Title |
Spotlight on HDL-raising Therapies: Insights From the Torcetrapib Trials |
| Url |
http://www.medscape.com/viewprogram/12498?src=rss |
| Description |
A large trial of a medication designed to raise HDL was stopped early because of a higher risk for death among subjects receiving active treatment. However, HDL-raising therapy may still have an important role in the prevention or management of cardiovascular disease. The current article reviews these treatments. Nature Clinical Practice Cardiovascular Medicine |
| Category |
Articles > Cardiology |
| Keywords |
|
| Date |
Apr 29, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Cardiology |
| 5. |
Genetic Guidance of Warfarin Dosing Shows Promise
|
|
|
Using genetic tests improved the accuracy and efficiency of warfarin dose initiation in the Couma-Gen study, but the primary end point of a reduction in out-of-range INRs was not significantly changed. Heartwire
|
|
|